Try a single issue or save on a subscription Issues delivered straight to your door or device ...

If you experience these symptoms, consider speaking with ... apnea in adults suspected of having moderate to severe obstructive sleep apnea without complicating conditions. However, they may ...

Despite the range of possible symptoms and risk factors ... was higher in cases that were more severe, regardless of a person’s age. Sleep apnea can pose both short- and long-term risks that ...

There are many consequences of untreated OSA, and all of these are more likely with more-severe obstruction. Because people ...

Left untreated, sleep apnea can lead to a range of serious health problems, many of which disproportionately affect women: • ...

Sleep apnea affects millions globally, often lurking undetected until it begins impacting overall health. While high blood ...

A loved one waking you with loud snoring, followed by gasping and choking sounds, might signal more than minor sleep ...

The FDA has approved Zepbound (tirzepatide) for the treatment of moderate to severe obstructive sleep apnea in adults with ...

Popular Eli Lilly weight-loss drug Zepbound can be covered by Medicare plans to treat sleep apnea after it received Food and ...

Awareness of sleep apnea and its relatively common and effective treatment has grown over the past three decades.

Averaging up to 20% of weight loss, adults taking Tirzepatide had at least 25 fewer breathing interruptions each hour as they ...

The U.S. Food and Drug Administration (FDA) recently approved Zepbound® (tirzepatide) as the first prescription medication for treating moderate-to-severe obstructive sleep apnea (OSA) in adults with ...